Overview
- Rigetti and D‑Wave shares have climbed more than 1,900% over the past year, ranking among the market’s strongest performers.
- Both companies now carry market values above $10 billion despite minimal revenue and continued cash burn.
- Current products have few real‑world uses, and significant revenue is not expected for years, underscoring uncertain commercialization timelines.
- The White House denied plans to buy stakes in quantum firms, even as the administration designates quantum development as a priority.
- Investor appetite persisted this week as Fidelity International backed a round valuing Quantinuum at $10 billion.